FDA Inspection 666402 — Holy Cross Hospital - IRB

Holy Cross Hospital - IRB — FEI 1052130

The FDA completed an inspection of Holy Cross Hospital - IRB on June 11, 2010 in Ft Lauderdale, FL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Biologics.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 11, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Ft Lauderdale, FL (United States)

Additional Details

IRB